Top Biotechnology companies in Germany by Price to Sales Ratio (P/S)

This ranking features the top 20 Biotechnology companies in Germany ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 4.57, for January 15, 2025.
#
Name
Price to Sales Ratio (P/S)
Reported Date
Stock Price
Change
Price (30 days) Country
1

15.87

Jan. 14, 2025 USD 3.95 -0.95%

Germany

2

13.12

Jan. 14, 2025 USD 5.29 13.28%

Germany

3

12.46

Jan. 14, 2025 USD 60.50 -1.24%

Germany

4

11.32

Jan. 14, 2025 USD 2.61 0.60%

Germany

5

6.73

Jan. 14, 2025 USD 116.36 -0.45%

Germany

6

6.51

Jan. 14, 2025 USD 4.96 -2.24%

Germany

7

5.24

Jan. 14, 2025 USD 1.49 -0.76%

Germany

8

3.76

Jan. 14, 2025 USD 48.95 1.72%

Germany

9

2.72

Jan. 14, 2025 USD 145.16 0.75%

Germany

10

2.47

Jan. 14, 2025 USD 1.09 3.54%

Germany

11

1.87

Jan. 14, 2025 USD 42.87 0.60%

Germany

12

1.67

Jan. 14, 2025 USD 8.09 -2.02%

Germany

13

1.40

Jan. 14, 2025 USD 3.68 1.46%

Germany

14

1.40

Jan. 14, 2025 USD 49.86 0.81%

Germany

15

1.22

Jan. 14, 2025 USD 29.11 3.16%

Germany

16

1.09

Jan. 14, 2025 USD 21.54 1.09%

Germany

17

0.86

Jan. 14, 2025 USD 4.18 0.60%

Germany

18

0.79

Feb. 28, 2024 USD 12.40 1.02%
NA

Germany

19

0.44

Jan. 14, 2025 USD 18.55 -3.93%

Germany

20

0.38

Jan. 14, 2025 USD 20.20 -1.60%

Germany

Frequently Asked Questions
  • Which Biotechnology company in Germany has the highest Price to Sales Ratio (P/S) ?

    The Biotechnology company in Germany with the highest Price to Sales Ratio (P/S) is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at 15.87.

  • Which Biotechnology company in Germany has the lowest Price to Sales Ratio (P/S) ?

    The Biotechnology company in Germany with the lowest Price to Sales Ratio (P/S) is Bayer Aktiengesellschaft (XETRA: BAYN.DE) at 0.38.